Replies to post #87704 on NorthWest Biotherapeutics Inc (NWBO)

[iwasadiver]

You need to read between the lines, go back to the PR's of this past year, the people they put on their board, NW didn't sell, the delisting, the timing of last night's PR and the timing of today's. Think it through given the dire straits they appeared to be in and the reasons for their silence. I've been saying Linda Powers is a genius, look at her resume. This is a play, and it's going to get even better.

[BioInfo]

"nvestigators have been unable to recruit additional subjects after a partial clinical hold was put into place in August 2015."

From Aug 2015 to Nov 2016, that is ummmm 15 months. so as of Aug 2015, 331 patients were enrolled, so we got 15 months worth OS in several folks in the trial. If it was futile, trial would have been stopped much sooner.

Another hint, ever wondered why bigpharma wanted to partner with NWBO? As much as FDA doesnt leak news, leaks do happen IMHO

[pgsd]

I believe there are two valid points to raise

1. IMO the reason they are able to tell us the number now could well
be that as they are choosing to not pursue recruiting the other 17 they can inform us. This is just my personal belief but we will probably have the answer on trial completion.

2. The company must be confident enough not just to ask for a check but that the PFS numbers would be good enough WITHOUT the other 17 patient's data being required.

I also think there is at least a possibility that this was released today to 'cushion' the negative effect of the delisting notice but again It is just IMO GLTA

[Poor Man -]

I was one of their biggest supporters, I still support them, but I am very skeptical of management based on their history of not following up or providing clarity. I was elated when they mentioned that they were going to do an internal and external investigation, we have yet to hear about that. I am elated to hear that they are requesting a read out, but I am not holding my breath that we get it in two weeks.

I can't place my finger on it, but there is something very, very odd about this management team and maybe even the governance. There is an ad hoc quality in terms of the way they go about their business, and I'm not sure they seek or get good advice.

Do they have a coherent strategy that we can make sense, or they just flying by the seat of their pants? Honestly, just can wait to meet these people to at least make sure they're not walking around with propeller beanies on their heads.